2023
Rapid Detection of SARS-CoV-2 RNA Using Reverse Transcription Recombinase Polymerase Amplification (RT-RPA) with Lateral Flow for N-Protein Gene and Variant-Specific Deletion-Insertion Mutation in S-Protein Gene.
Malaga JL, Pajuelo MJ, Okamoto M, Tsinda EK, Otani K, Tsukayama P, Mascaro L, Cuicapuza D, Katsumi M, Kawamura K, Nishimura H, Sakagami A, Ueki Y, Omiya S, Okamoto S, Nakayama A, Fujimaki SI, Yu C, Azam S, Kodama E, Dapat C, Oshitani H, Saito M.
Viruses. 2023 May 26;15(6):1254. doi: 10.3390/v15061254. PMID: 37376555PubMed.
Malaga JL, Pajuelo MJ, Okamoto M, Tsinda EK, Otani K, Tsukayama P, Mascaro L, Cuicapuza D, Katsumi M, Kawamura K, Nishimura H, Sakagami A, Ueki Y, Omiya S, Okamoto S, Nakayama A, Fujimaki SI, Yu C, Azam S, Kodama E, Dapat C, Oshitani H, Saito M.
Viruses. 2023 May 26;15(6):1254. doi: 10.3390/v15061254. PMID: 37376555PubMed.
Prioritising respiratory syncytial virus prevention in low-income and middle-income countries.
Xavier Carbonell-Estrany, Eric Af Simões, Louis J Bont, Bosco A Paes; RSV Prevention Collaborators.
Lancet Glob Health. 2023 May;11(5):e655-e657. doi: 10.1016/S2214-109X(23)00165-1. PMID: 37061306.PubMed.
Xavier Carbonell-Estrany, Eric Af Simões, Louis J Bont, Bosco A Paes; RSV Prevention Collaborators.
Lancet Glob Health. 2023 May;11(5):e655-e657. doi: 10.1016/S2214-109X(23)00165-1. PMID: 37061306.PubMed.
International platform trials: as diseases cross borders, so should trials.
Hiroki Saito; Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) investigators.
Lancet Infect Dis. 2023 Mar 23;S1473-3099(23)00193-7. doi: 10.1016/S1473-3099(23)00193-7. Online ahead of print.PubMed.
Hiroki Saito; Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) investigators.
Lancet Infect Dis. 2023 Mar 23;S1473-3099(23)00193-7. doi: 10.1016/S1473-3099(23)00193-7. Online ahead of print.PubMed.
Promote global solidarity to advance health-system resilience: proposals for the G7 meetings in Japan.
Lancet. 2023 Apr 4;S0140-6736(23)00690-6. doi: 10.1016/S0140-6736(23)00690-6. Online ahead of print.PubMed.
Lancet. 2023 Apr 4;S0140-6736(23)00690-6. doi: 10.1016/S0140-6736(23)00690-6. Online ahead of print.PubMed.
Seroprevalence of four endemic human coronaviruses and, reactivity and neutralization capability against SARS-CoV-2 among children in the Philippines.
Sayama Y, Okamoto M, Saito M, Saito-Obata M, Tamaki R, Joboco CD, Lupisan S, Oshitani H.
Sci Rep. 2023 Feb 9;13(1):2310. doi: 10.1038/s41598-023-29072-3. PMID: 36759702; PMCID: PMC9909632.PubMed.
Sayama Y, Okamoto M, Saito M, Saito-Obata M, Tamaki R, Joboco CD, Lupisan S, Oshitani H.
Sci Rep. 2023 Feb 9;13(1):2310. doi: 10.1038/s41598-023-29072-3. PMID: 36759702; PMCID: PMC9909632.PubMed.
Transmission of COVID-19 in Nightlife, Household, and Health Care Settings in Tokyo, Japan, in 2020.
Imamura T, Watanabe A, Serizawa Y, Nakashita M, Saito M, Okada M, Ogawa A, Tabei Y, Soumura Y, Nadaoka Y, Nakatsubo N, Chiba T, Sadamasu K, Yoshimura K, Noda Y, Iwashita Y, Ishimaru Y, Seki N, Otani K, Imamura T, Griffith M M, DeToy K, Suzuki M, Yoshida M, Tanaka A, Yauchi M, Shimada T, Oshitani H,
JAMA Netw Open. 2023;6(2):e230589. doi:10.1001/jamanetworkopen.2023.0589PubMed.
Imamura T, Watanabe A, Serizawa Y, Nakashita M, Saito M, Okada M, Ogawa A, Tabei Y, Soumura Y, Nadaoka Y, Nakatsubo N, Chiba T, Sadamasu K, Yoshimura K, Noda Y, Iwashita Y, Ishimaru Y, Seki N, Otani K, Imamura T, Griffith M M, DeToy K, Suzuki M, Yoshida M, Tanaka A, Yauchi M, Shimada T, Oshitani H,
JAMA Netw Open. 2023;6(2):e230589. doi:10.1001/jamanetworkopen.2023.0589PubMed.